There’s Another Big Weight Loss Drug Coming — and It’s Not Made by Lilly

April 27, 2026

CagriSema FDA approval submission filed Dec 2025 by Novo Nordisk. 22.7% weight loss in REDEFINE 1, beat semaglutide alone. Here’s how it stacks up to tirzepatide and retatrutide.

The 14 Banned Peptides Quietly Coming Back to Your Pharmacy

April 26, 2026

The FDA reclassified 14 banned peptides in February 2026 — BPC-157, GHK-Cu, Thymosin Alpha-1, and more. Here’s what’s actually changing, what isn’t, and the timeline.

Move Over, Ozempic — The Drug That Just Crushed Every Weight Loss Record

April 26, 2026

Retatrutide weight loss results from TRIUMPH-4: 28.7% body weight reduction (71 lbs avg). Beats Ozempic and Zepbound. Here’s what Eli Lilly’s Phase 3 data actually showed.